DK329289A - NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS - Google Patents

NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS Download PDF

Info

Publication number
DK329289A
DK329289A DK329289A DK329289A DK329289A DK 329289 A DK329289 A DK 329289A DK 329289 A DK329289 A DK 329289A DK 329289 A DK329289 A DK 329289A DK 329289 A DK329289 A DK 329289A
Authority
DK
Denmark
Prior art keywords
receptor
therapeutic use
new therapeutic
breaking compounds
breaking
Prior art date
Application number
DK329289A
Other languages
Danish (da)
Other versions
DK329289D0 (en
Inventor
Rolf Haakanson
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK329289D0 publication Critical patent/DK329289D0/en
Publication of DK329289A publication Critical patent/DK329289A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK329289A 1987-11-13 1989-07-03 NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS DK329289A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704436A SE8704436D0 (en) 1987-11-13 1987-11-13 USE OF ANTI-SECRETARY SUBSTANCES FOR NEW INDICATIONS
PCT/SE1988/000574 WO1989004178A1 (en) 1987-11-13 1988-10-27 New therapeutical use of h2-receptor-blocking compounds

Publications (2)

Publication Number Publication Date
DK329289D0 DK329289D0 (en) 1989-07-03
DK329289A true DK329289A (en) 1989-07-03

Family

ID=20370204

Family Applications (1)

Application Number Title Priority Date Filing Date
DK329289A DK329289A (en) 1987-11-13 1989-07-03 NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS

Country Status (7)

Country Link
EP (1) EP0353262A1 (en)
JP (1) JPH02502188A (en)
AU (1) AU2720388A (en)
DK (1) DK329289A (en)
HU (1) HUT51894A (en)
SE (1) SE8704436D0 (en)
WO (1) WO1989004178A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
EE05603B1 (en) * 1997-07-22 2012-12-17 Merck & Co., Inc. Use of alendronate in the manufacture of a medicament for the treatment of osteoporosis
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113181110A (en) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 Liquid aqueous pharmaceutical composition containing preserved etherified cyclodextrin derivatives
BR112016011111B1 (en) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh IMPROVED PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4220653A (en) * 1979-01-24 1980-09-02 Vivino A Earl Administration of cimetidine to reduce appetite and facilitate weight loss in persons suffering from excessive weight
US4256743A (en) * 1979-02-22 1981-03-17 President And Fellows Of Harvard College Inhibition of bone resorption with H1 -blocking antihistamines
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
DK329289D0 (en) 1989-07-03
JPH02502188A (en) 1990-07-19
SE8704436D0 (en) 1987-11-13
AU2720388A (en) 1989-06-01
HUT51894A (en) 1990-06-28
WO1989004178A1 (en) 1989-05-18
HU886797D0 (en) 1990-05-28
EP0353262A1 (en) 1990-02-07

Similar Documents

Publication Publication Date Title
GR871212B (en) Therapeutic use of serotonin antagonist
DK208188A (en) USE OF 17-KETOSTEROIDS
DK263288D0 (en) PHARMACEUTICAL PREPARATION OF CEFUROXIM-AXETIL
DK363887A (en) USE OF BROMCRUPTIN
DK399088D0 (en) USE OF OLEFINE COMPOUNDS
DK329289D0 (en) NEW THERAPEUTIC USE OF H2 RECEPTOR BREAKING COMPOUNDS
IT8722783A0 (en) AMIKACIN SYNTHESIS PROCEDURE
DK185988A (en) USE OF ANTIGEN
DK365588A (en) EQUIPMENT TL ESTABLISHMENT OF ANCHORING ELEMENTS
DK537687D0 (en) PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED PIPERAZINONS
DK293086A (en) USE OF SUBSTITUTED AZABICYCLO COMPOUNDS
DK87888D0 (en) THERAPEUTIC USE OF TINDIODDEUTEROPORFYRIN
DK316589D0 (en) SUBSTITUTED AZACYCLOHEXYL DERIVATIVES OF RIFAMYCINES
IT1158450B (en) PROCEDURE FOR THE PREPARATION OF ERYTHRO-ALPHA-2-PIPERIDYL-2,8-BIS- (TRIFLUOROMETHYL) -4-QUINOLINMETHANOL
DK415087D0 (en) THERAPEUTIC AGENTS CONTAINING BENZHYDRYLTHIOMETHER DERIVATIVES
DK245388A (en) USE OF DOPAMINE RECEPTOR AGONISTS
DK175587A (en) PREPARATION OF SUBSTITUTED (DICHLORMETHYL) -PYRIDINES
DK471287D0 (en) PREPARATION OF SUBSTITUTED AMID
DK115088A (en) DEVICE FOR COMPOSITION OF CONSTRUCTION PARTS
ZA893146B (en) Therapeutic use of serotonin antagonists
KR870011914U (en) Detachable structure of detachable foundation
ZA903015B (en) Therapeutic use of 5-ht3 receptor antagonists
IT8748006A0 (en) EARPHONE COVER DEVICE FOR THE HYGIENIC PROTECTION OF TELEPHONE USERS
ES292771Y (en) THERAPEUTIC RING
IT8821146A0 (en) IMPROVED DEVICE FOR PURIFICATION OF WATER.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment